These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 27363508)

  • 21. Baseline demographics, clinical features and predictors of conversion among 200 individuals in a longitudinal prospective psychosis-risk cohort.
    Brucato G; Masucci MD; Arndt LY; Ben-David S; Colibazzi T; Corcoran CM; Crumbley AH; Crump FM; Gill KE; Kimhy D; Lister A; Schobel SA; Yang LH; Lieberman JA; Girgis RR
    Psychol Med; 2017 Aug; 47(11):1923-1935. PubMed ID: 28249639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toward Generalizable and Transdiagnostic Tools for Psychosis Prediction: An Independent Validation and Improvement of the NAPLS-2 Risk Calculator in the Multisite PRONIA Cohort.
    Koutsouleris N; Worthington M; Dwyer DB; Kambeitz-Ilankovic L; Sanfelici R; Fusar-Poli P; Rosen M; Ruhrmann S; Anticevic A; Addington J; Perkins DO; Bearden CE; Cornblatt BA; Cadenhead KS; Mathalon DH; McGlashan T; Seidman L; Tsuang M; Walker EF; Woods SW; Falkai P; Lencer R; Bertolino A; Kambeitz J; Schultze-Lutter F; Meisenzahl E; Salokangas RKR; Hietala J; Brambilla P; Upthegrove R; Borgwardt S; Wood S; Gur RE; McGuire P; Cannon TD
    Biol Psychiatry; 2021 Nov; 90(9):632-642. PubMed ID: 34482951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Early Psychosis Screener (EPS): Quantitative validation against the SIPS using machine learning.
    Brodey BB; Girgis RR; Favorov OV; Addington J; Perkins DO; Bearden CE; Woods SW; Walker EF; Cornblatt BA; Brucato G; Walsh B; Elkin KA; Brodey IS
    Schizophr Res; 2018 Jul; 197():516-521. PubMed ID: 29358019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severity of thought disorder predicts psychosis in persons at clinical high-risk.
    Perkins DO; Jeffries CD; Cornblatt BA; Woods SW; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Heinssen R; Mathalon DH; Seidman LJ; Tsuang MT; Walker EF; McGlashan TH
    Schizophr Res; 2015 Dec; 169(1-3):169-177. PubMed ID: 26441004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Symptomatic and functional outcome in youth at ultra-high risk for psychosis: a longitudinal study.
    Lemos-Giráldez S; Vallina-Fernández O; Fernández-Iglesias P; Vallejo-Seco G; Fonseca-Pedrero E; Paíno-Piñeiro M; Sierra-Baigrie S; García-Pelayo P; Pedrejón-Molino C; Alonso-Bada S; Gutiérrez-Pérez A; Ortega-Ferrández JA
    Schizophr Res; 2009 Dec; 115(2-3):121-9. PubMed ID: 19786339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting the individual risk of psychosis conversion in at-risk mental state (ARMS): a multivariate model reveals the influence of nonpsychotic prodromal symptoms.
    Bourgin J; Duchesnay E; Magaud E; Gaillard R; Kazes M; Krebs MO
    Eur Child Adolesc Psychiatry; 2020 Nov; 29(11):1525-1535. PubMed ID: 31872289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of Machine Learning to Determine Deviance in Neuroanatomical Maturity Associated With Future Psychosis in Youths at Clinically High Risk.
    Chung Y; Addington J; Bearden CE; Cadenhead K; Cornblatt B; Mathalon DH; McGlashan T; Perkins D; Seidman LJ; Tsuang M; Walker E; Woods SW; McEwen S; van Erp TGM; Cannon TD;
    JAMA Psychiatry; 2018 Sep; 75(9):960-968. PubMed ID: 29971330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Course of psychotic symptoms, depression and global functioning in persons at clinical high risk of psychosis: Results of a longitudinal observation study over three years focusing on both converters and non-converters.
    Hengartner MP; Heekeren K; Dvorsky D; Walitza S; Rössler W; Theodoridou A
    Schizophr Res; 2017 Nov; 189():19-26. PubMed ID: 28139360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early prodromal symptoms can predict future psychosis in familial high-risk youth.
    Tandon N; Montrose D; Shah J; Rajarethinam RP; Diwadkar VA; Keshavan MS
    J Psychiatr Res; 2012 Jan; 46(1):105-10. PubMed ID: 22056319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropsychological Test Performance to Enhance Identification of Subjects at Clinical High Risk for Psychosis and to Be Most Promising for Predictive Algorithms for Conversion to Psychosis: A Meta-Analysis.
    Hauser M; Zhang JP; Sheridan EM; Burdick KE; Mogil R; Kane JM; Auther A; Carrión RE; Cornblatt BA; Correll CU
    J Clin Psychiatry; 2017 Jan; 78(1):e28-e40. PubMed ID: 28129494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poor functional recovery is better predicted than conversion in studies of outcomes of clinical high risk of psychosis: insight from SHARP.
    Zhang T; Yang S; Xu L; Tang X; Wei Y; Cui H; Li H; Tang Y; Hui L; Li C; Chen X; Wang J
    Psychol Med; 2020 Jul; 50(9):1578-1584. PubMed ID: 31451124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Early detection of psychotic disorders].
    Schäfer MR; Klier CM; Papageorgiou K; Friedrich MH; Amminger GP
    Neuropsychiatr; 2007; 21(1):37-44. PubMed ID: 17555006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Movement disorders as a prodromal sign in individuals at high risk of psychosis].
    van Harten PN; Bakker PR; van Os J
    Tijdschr Psychiatr; 2015; 57(2):77-82. PubMed ID: 25669942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurocognitive function as a possible marker for remission from clinical high risk for psychosis.
    Lee TY; Shin YS; Shin NY; Kim SN; Jang JH; Kang DH; Kwon JS
    Schizophr Res; 2014 Mar; 153(1-3):48-53. PubMed ID: 24529365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychosis-like experiences and distress among adolescents using mental health services.
    Kline E; Thompson E; Bussell K; Pitts SC; Reeves G; Schiffman J
    Schizophr Res; 2014 Feb; 152(2-3):498-502. PubMed ID: 24411529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Premorbid functional development and conversion to psychosis in clinical high-risk youths.
    Tarbox SI; Addington J; Cadenhead KS; Cannon TD; Cornblatt BA; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Heinssen R; McGlashan TH; Woods SW
    Dev Psychopathol; 2013 Nov; 25(4 Pt 1):1171-86. PubMed ID: 24229556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of psychiatric comorbidity in individuals at Ultra High Risk of psychosis - Findings from the Longitudinal Youth at Risk Study (LYRIKS).
    Lim J; Rekhi G; Rapisarda A; Lam M; Kraus M; Keefe RS; Lee J
    Schizophr Res; 2015 May; 164(1-3):8-14. PubMed ID: 25818728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving prediction of psychosis in youth at clinical high-risk: pre-baseline symptom duration and cortical thinning as moderators of the NAPLS2 risk calculator.
    Worthington MA; Collins MA; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Keshavan M; Mathalon DH; Perkins DO; Stone WS; Walker EF; Woods SW; Cannon TD
    Psychol Med; 2024 Feb; 54(3):611-619. PubMed ID: 37642172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying youth at risk for psychosis using the Behavior Assessment System for Children, Second Edition.
    Thompson E; Kline E; Reeves G; Pitts SC; Schiffman J
    Schizophr Res; 2013 Dec; 151(1-3):238-44. PubMed ID: 24119463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic Prediction of Outcomes for Youth at Clinical High Risk for Psychosis: A Joint Modeling Approach.
    Worthington MA; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Keshavan M; Lympus CA; Mathalon DH; Perkins DO; Stone WS; Walker EF; Woods SW; Zhao Y; Cannon TD
    JAMA Psychiatry; 2023 Oct; 80(10):1017-1025. PubMed ID: 37531131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.